Moneycontrol PRO
HomeNewsBusinessMoneycontrol ResearchCadila: COVID vaccine to be the key differentiator in the near term

Cadila: COVID vaccine to be the key differentiator in the near term

In the next fiscal, Cadila plans to launch 40-plus products, including 8-10 complex molecules which should offset pricing erosion

February 09, 2021 / 09:50 IST
  • PRO Panorama

    Moneycontrol Pro Panorama | Lessons from Eli Lilly in corporate longevity

    Nov 25, 2025 / 02:43 PM IST

    In Moneycontrol Pro Panorama November 25 edition: Labour Codes do not create flexible work environment legal, rate cuts may revive...

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | Samvat 2082: The Will to Rise

    Oct 18, 2025 / 10:00 AM IST

    After a turbulent Samvat 2081, the markets step into the new year not with fireworks but with quiet resolve and the will to rise

    Read Now
Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts

Disclosure & Disclaimer

This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More